Journal article icon

Journal article

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

Abstract:

OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease. INTERVENTION: Patients randomly assigned to galantamine had their daily dose escalated over three to four weeks to maintenance doses of 24 or 32 mg. MAIN OUTCOME MEASURES: Scores on the 11 item ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/bmj.321.7274.1445

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
Role:
Author
Journal:
BMJ (Clinical research ed.)
Volume:
321
Issue:
7274
Pages:
1445-1449
Publication date:
2000-12-05
DOI:
EISSN:
1756-1833
ISSN:
0959-8138
URN:
uuid:40c9f731-6013-4ff5-aa2a-c022485f323f
Source identifiers:
37674
Local pid:
pubs:37674

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP